Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Shereen A Sayed, Ehsan A B Hassan, Muhamad R Abdel Hameed, Michael N Agban, Mostafa F Mohammed Saleh, Hayam H Mohammed, Abu-Baker M Abdel-Aal & Sherein G Elgendy. (2021) Ketorolac-fluconazole: A New Combination Reverting Resistance in Candida albicans from Acute Myeloid Leukemia Patients on Induction Chemotherapy: In vitro Study. Journal of Blood Medicine 12, pages 465-474.
Read now
Read now
Seyededeh Sedigheh Hosseini, Hamidreza Joshaghani, Tahereh Shokohi, Alireza Ahmadi & Zahra Mehrbakhsh. (2020) Antifungal Activity of ZnO Nanoparticles and Nystatin and Downregulation of SAP1-3 Genes Expression in Fluconazole-Resistant Candida albicans Isolates from Vulvovaginal Candidiasis. Infection and Drug Resistance 13, pages 385-394.
Read now
Read now
Daniel F. Valenzuela-Cota, Génesis V. Buitimea-Cantúa, Maribel Plascencia-Jatomea, Francisco J. Cinco-Moroyoqui, Aarón A. Martínez-Higuera & Ema C. Rosas-Burgos. (2019) Inhibition of the antioxidant activity of catalase and superoxide dismutase from Fusarium verticillioides exposed to a Jacquinia macrocarpa antifungal fraction. Journal of Environmental Science and Health, Part B 54:8, pages 647-654.
Read now
Read now
ZeBin Liao, ZhenYu Zhu, Ling Li, Liang Wang, Hui Wang, YuanYing Jiang & YingYing Cao. (2019) Metabonomics on Candida albicans indicate the excessive H3K56ac is involved in the antifungal activity of Shikonin. Emerging Microbes & Infections 8:1, pages 1243-1253.
Read now
Read now
Zebin Liao, Yu Yan, Huaihuai Dong, Zhenyu Zhu, Yuanying Jiang & Yingying Cao. (2016) Endogenous nitric oxide accumulation is involved in the antifungal activity of Shikonin against Candida albicans. Emerging Microbes & Infections 5:1, pages 1-6.
Read now
Read now
Alfonso Javier Carrillo-Muñoz, Cristina Tur-Tur, Gustavo Giusiano, Cristina Marcos-Arias, Elena Eraso, Nerea Jauregizar & Guillermo Quindós. (2013) Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis. Expert Review of Anti-infective Therapy 11:4, pages 347-358.
Read now
Read now
Chiara Calugi, Andrea Trabocchi & Antonio Guarna. (2011) Novel small molecules for the treatment of infections caused by Candida albicans: a patent review (2002 – 2010). Expert Opinion on Therapeutic Patents 21:3, pages 381-397.
Read now
Read now
Maria Teresa Fera, Erminia La Camera & Angelina De Sarro. (2009) New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Expert Review of Anti-infective Therapy 7:8, pages 981-998.
Read now
Read now
M Anaul Kabir & Mohammad Asif Hussain. (2009) Human fungal pathogen Candida albicans in the postgenomic era: an overview. Expert Review of Anti-infective Therapy 7:1, pages 121-134.
Read now
Read now
Stefan Langner, Philipp B Staber & Peter Neumeister. (2008) Posaconazole in the management of refractory invasive fungal infections. Therapeutics and Clinical Risk Management 4:4, pages 747-758.
Read now
Read now
Riina Rautemaa, Malcolm Richardson, Michael Pfaller, Jaakko Perheentupa & Harri Saxén. (2008) Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole. Scandinavian Journal of Infectious Diseases 40:11-12, pages 904-907.
Read now
Read now
Douglas S Kwon & Eleftherios Mylonakis. (2007) Posaconazole: a new broad-spectrum antifungal agent. Expert Opinion on Pharmacotherapy 8:8, pages 1167-1178.
Read now
Read now